新加坡

    新加坡的目标是成为世界医疗技术中心，这个城邦国家为此制定了一揽子激励计划，以吸引大型公司和商界新贵来此落户。该国推出的项目包括税收抵免研发开支，并且可以使用新加坡先进的电信基础设施，以及从新加坡一流工程学院毕业的科技人才。如今，这些激励措施似乎正在发挥作用：近几年，医药行业巨头葛兰素史克公司（GlaxoSmithKline）、诺华制药（Novartis）、雅培制药（Abbott）和罗氏公司（Roche）均开始在新加坡大规模开展业务。

优势

    •科技

    •教育

    •对公司有利的政策

Singapore

    Singapore has its sights set on becoming a hub for health technology, and the city-state has developed a package of incentives to lure large employers and upstarts alike. The program includes tax credits for R&D spending, plus access to Singapore's cutting-edge telecom infrastructure and scientific talent graduating from the country's highly ranked engineering programs. The inducements seem to be working: In recent years pharmaceutical giants GlaxoSmithKline, Novartis, Abbott, and Roche have opened major operations in Singapore.

Good for

    •Science

    •Education

    •Business-friendly policies